Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRNE
4851
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $205K | ﹤0.01% |
95,578
+20,162
| +27% | +$47K |
|
|
FNHC
4852
DELISTED
FedNat Holding Company Common Stock
FNHC
| $205K | ﹤0.01% |
14,614
+1,043
| +8% | +$13.6K |
|
4853
Universal Logistics Holdings
ULH
$480M
| $204K | ﹤0.01% |
8,791
-1,150
| -12% | -$24.9K |
|
|
IPG
4854
PUT
DELISTED
Interpublic Group of Companies
IPG
| $203K | ﹤0.01% |
+9,400
| New | +$203K |
|
4855
Arcus Biosciences
RCUS
$3.47B
| $203K | ﹤0.01% |
22,213
-28,392
| -56% | -$228K |
|
|
PTR
4856
PUT
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $203K | ﹤0.01% |
4,000
-6,500
| -62% | -$337K |
|
4857
Axsome Therapeutics
AXSM
$10.9B
| $202K | ﹤0.01% |
10,000
-35,660
| -78% | -$916K |
|
4858
PUT
Coty
COTY
$2.46B
| $202K | ﹤0.01% |
19,200
-228,800
| -92% | -$2.37M |
|
4859
CALL
Crane NXT
CXT
$3.09B
| $202K | ﹤0.01% |
7,197
+6,909
| +2,399% | +$193K |
|
4860
PUT
Fortune Brands Innovations
FBIN
$6.22B
| $202K | ﹤0.01% |
4,329
-31,707
| -88% | -$1.44M |
|
4861
KLX Energy Services
KLXE
$44.4M
| $202K | ﹤0.01% |
4,647
-1,230
| -21% | -$82K |
|
4862
CALL
Pool Corp
POOL
$7.11B
| $202K | ﹤0.01% |
1,000
-1,800
| -64% | -$347K |
|
4863
Integra LifeSciences
IART
$1.39B
| $201K | ﹤0.01% |
3,349
-78,956
| -96% | -$4.7M |
|
4864
Liquidity Services
LQDT
$1.23B
| $201K | ﹤0.01% |
27,180
-4,289
| -14% | -$29.6K |
|
4865
ProShares VIX Short-Term Futures ETF
VIXY
$190M
| $201K | ﹤0.01% |
+129
| New | +$211K |
|
4866
PUT
National Beverage
FIZZ
$2.95B
| $200K | ﹤0.01% |
9,000
+8,600
| +2,150% | +$186K |
|
4867
Philips
PHG
$25.6B
| $200K | ﹤0.01% |
+5,437
| New | +$200K |
|
|
BRG
4868
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $200K | ﹤0.01% |
16,922
-3,404
| -17% | -$40.7K |
|
|
GRA
4869
PUT
DELISTED
W.R. Grace & Co.
GRA
| $200K | ﹤0.01% |
3,000
+500
| +20% | +$35K |
|
4870
PUT
Cemex
CX
$17.1B
| $199K | ﹤0.01% |
50,700
+33,600
| +196% | +$123K |
|
|
SCTL
4871
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $199K | ﹤0.01% |
20,020
-1,107
| -5% | -$10.8K |
|
|
ACBI
4872
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $199K | ﹤0.01% |
11,501
-4,859
| -30% | -$84.4K |
|
4873
Amneal Pharmaceuticals
AMRX
$6.02B
| $198K | ﹤0.01% |
68,093
-201,546
| -75% | -$703K |
|
4874
Smith Micro Software
SMSI
$14.8M
| $198K | ﹤0.01% |
914
+913
| +91,300% | +$188K |
|
4875
PUT
Sunoco
SUN
$14.6B
| $198K | ﹤0.01% |
6,300
+5,700
| +950% | +$182K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.